General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Sep. 30, 2011
Sep. 30, 2010
REVENUES        
Neurometric Information Services $ 32,000 $ 27,300 $ 111,400 $ 136,100
Clinical Services 152,300 120,600 634,500 502,400
Sales Revenue, Services, Net 184,300 147,900 745,900 638,500
OPERATING EXPENSES        
Cost of neurometric services revenues 39,200 36,100 147,100 135,100
Research 69,700 211,000 482,800 738,800
Product development 112,500 144,400 442,000 381,700
Sales and marketing 330,000 246,700 1,231,500 870,900
General and administrative 1,061,300 1,053,800 4,271,900 5,017,000
Total operating expenses 1,612,700 1,692,000 6,575,300 7,143,500
OPERATING LOSS (1,428,400) (1,544,100) (5,829,400) (6,505,000)
OTHER INCOME (EXPENSE)        
Interest income (expense), net (1,482,000) (2,627,100) (7,567,000) (360,500)
Loss on extinguishment of debt     (1,968,000) (1,094,300)
Financing fees (45,300) (142,700) (348,600) (213,400)
Offering costs (6,800) 0 (437,800) 0
Other non-operating income     458,800 0
Gain on derivative liabilities 232,100 4,217,500 6,826,700 0
Total other income (expense) (1,302,000) 1,447,700 (3,035,900) (1,668,200)
LOSS BEFORE INCOME TAXES (2,730,400) (96,400) (8,865,300) (8,173,200)
Income taxes 900 1,300 1,300 800
NET LOSS $ (2,731,300) $ (97,700) $ (8,866,600) $ (8,174,000)
NET LOSS PER SHARE:        
Basic (in dollars per share) $ (1.46) $ (0.05) $ (4.74) $ (4.69)
Diluted (in dollars per share) $ (1.46) $ (0.05) $ (4.74) $ (4.69)
WEIGHTED AVERAGE SHARES OUTSTANDING:        
Basic (in shares) 1,873,584 1,867,464 1,869,038 1,742,570
Diluted (in shares) 1,873,584 1,867,464 1,869,038 1,742,570